Maresin 1 Alleviates Diabetic Kidney Disease via LGR6-Mediated cAMP-SOD2-ROS Pathway

Background. Chronic hyperglycemia-induced inflammation is recognized as the most important pathophysiological process in diabetic kidney disease (DKD). As maresin 1 (MaR1) is an extensive anti-inflammatory lipid mediator, the present study investigated the protective role of MaR1 in the pathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xinyue, Xu, Butuo, Wu, Jing, Pu, Yueli, Wan, Shengrong, Zeng, Yan, Wang, Mei, Luo, Lifang, Zhang, Fanjie, Jiang, Zongzhe, Xu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042615/
https://www.ncbi.nlm.nih.gov/pubmed/35498124
http://dx.doi.org/10.1155/2022/7177889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9042615/
https://www.ncbi.nlm.nih.gov/pubmed/35498124
http://dx.doi.org/10.1155/2022/7177889

Ejemplares similares